-
Agirre A, Barco A, Carrasco L. Viroporin-mediated membrane permeabilization. Pore formation by nonstructural poliovirus 2B protein.[J]. J Biol Chem, 2002, 277(): 40034-40441.
-
Becker C F W, Oblatt-Montal M, Kochendoerfer G G. Chemical synthesis and single channel properties of tetrameric and pentameric TASPs (template-assembled synthetic proteins) derived from the trans-membrane domain of HIV virus protein u (Vpu)[J]. J Biol Chem, 2004, 279(): 17483-17489. doi: 10.1074/jbc.M313212200
-
Benjamin J, Chen G P L, David Jackson, Robert A Lamb. The Influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding[J]. J Virol, 2008, 82(): 10059-10070. doi: 10.1128/JVI.01184-08
-
Betakova T, Hay A J. Evidence that the CM2 protein of influenza C virus can modify the pH of the exocytic pathway of transfected cells[J]. J Gen Virol, 2007, 88(): 2291-2296. doi: 10.1099/vir.0.82785-0
-
Bour S S U, Strebel K. The Human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4-implications for the mechanism degradation[J]. J Virol, 1995, 69(): 1510-1520.
-
Cady S. D, Hong M. Amantadine-induced conformational and dynamical changes of the influenza M2 transmembrane proton channel[J]. Proc Natl Acad Sci USA, 2008, 105(): 1483-1488. doi: 10.1073/pnas.0711500105
-
Carrasco L G R, Irurzun A, Barco A. Effects of viral replication on cellular membrane metabolism and function[J]. Mol Biol Picorna Virus, 2002, (): 337-354.
-
Carrere-Kremer S, Montpellier-Pala C, Cocquerel L. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus[J]. J Virol, 2002, 76(): 3720-3730. doi: 10.1128/JVI.76.8.3720-3730.2002
-
Chen H, Wu Y, Voth G A. Proton transport behavior through the influenza A M2 channel: insights from molecular simulation[J]. Biophys J, 2007, 93(): 3470-3479. doi: 10.1529/biophysj.107.105742
-
Clarke D, Griffin S, Beales L. Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro[J]. J Biolog Chem, 2006, 281(): 37057-37068. doi: 10.1074/jbc.M602434200
-
Cohen E A, Terwilliger E F, Sodroski J G. Identification of a protein encoded by the Vpu gene of HIV-1[J]. Nature, 1988, 334(): 532-534. doi: 10.1038/334532a0
-
Cross T A. Flu BM2 structure and function[J]. Nat Struc Mol Biol, 2009, 16(): 1207-1209. doi: 10.1038/nsmb1209-1207
-
Davies W L, Hoffmann C E, Paulshock M. Antiviral activity of 1-adamantanamine (amantadine)[J]. Science, 1964, 144(): 862-863. doi: 10.1126/science.144.3620.862
-
De Jong A S, Wessels E, Dijkman H B. Determinants for membrane association and permea-bilization of the coxsackievirus 2B protein and the identification of the Golgi complex as the target organelle[J]. J Biol Chem, 2003, 278(): 1012-1021. doi: 10.1074/jbc.M207745200
-
De Jong A S, Melchers W J, Glaudemans D H. Mutational analysis of different regions in the coxsackievirus 2B protein: Requirements for homomulti-merization, membrane permeabilization, subcellular localization, and virus replication[J]. J Biol Chem, 2004, 279(): 19924-19935. doi: 10.1074/jbc.M314094200
-
Deltenre P, Henrion J, Canva V. Evaluation of amantadine in chronic hepatitis C: a meta-analysis[J]. J Hepatol, 2004, 41(): 462-473. doi: 10.1016/j.jhep.2004.05.019
-
Feld J J, Hoofnagle J H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C[J]. Nature (London), 2005, 436(): 967-972. doi: 10.1038/nature04082
-
Fischer W. 2005. Viral Memberane Proteins: Structure, Function and Drug Design. Chapter 15. New York: Kluwer Academic/Plenum Publisher.
-
Fischer W B, Pitkeathly M, Sansom M S P. Amantadine blocks channel activity of the transmembrane segment of the NB protein from influenza B[J]. Eur Biophys J Biophy Letters, 2001, 30(): 416-420. doi: 10.1007/s002490100157
-
Fisher W B, Kruger gens. Viral channel-forming proteins[J]. Inter Rev Cell Mol Biol, 2009, 275(): 35-63. doi: 10.1016/S1937-6448(09)75002-6
-
Fischer W B, Sansom M S P. Viral ion channels: structure and function[J]. Biochim Biophys Acta, 2002, 1561(): 27-45. doi: 10.1016/S0304-4157(01)00009-0
-
Forrest L R, Kukol A, Arkin I T. Exploring models of the influenza A M2 channel: MD simulations in a phospholipid bilayer[J]. Biophys J, 2000, 78(): 55-69. doi: 10.1016/S0006-3495(00)76572-6
-
Forrest L R, DeGrado W F, Dieckmann G R. Two models of the influenza A M2 channel domain: verification by comparison[J]. Fold Des, 1998, 3(): 443-448. doi: 10.1016/S1359-0278(98)00061-3
-
Gage W P, Gary E, et al. 2005. Virus Ion Channels Formed by Vpu of HIV-1, the 6K Protein of Alphaviruses and NB of Influenza B Virus. In: Viral Membrane Proteins: Structure, Function, and Drug Design (Fischer W B, Ewart G, Melton J, et al. eds. ), New York: Kluwer Academic/Plenum Publishers. p207-231.
-
Giffin K, Rader R K, Marino M H. Novel assay for the influenza virus M2 channel activity[J]. FEBS Lett, 1995, 357(): 269-274. doi: 10.1016/0014-5793(94)01369-C
-
Gonzalez M E, Carrasco L. Viroporins[J]. FEBS Lett, 2003, 552(): 28-34. doi: 10.1016/S0014-5793(03)00780-4
-
Grambas S, Bennett M S, Hay A J. Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses[J]. Virology, 1992, 191(): 541-549. doi: 10.1016/0042-6822(92)90229-I
-
Grantham M L, Wu W H, Lalime E N. Palmitoylation of the influenza A virus M2 protein is not required for virus replication in vitro but contributes to virus virulence[J]. J Virol, 2009, 83(): 8655-8661. doi: 10.1128/JVI.01129-09
-
Griffin S, Clarke D, McCormick C. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes[J]. J Virol, 2005, 79(): 15525-15536. doi: 10.1128/JVI.79.24.15525-15536.2005
-
Griffin S, StGelais C, Owsianka A M. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel[J]. Hepatology, 2008, 48(): 1779-1790. doi: 10.1002/hep.22555
-
Griffin S D C, Beales L P, Clarke D S. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine[J]. FEBS Lett, 2003, 535(): 34-38. doi: 10.1016/S0014-5793(02)03851-6
-
Griffin S D C, Harvey R, Clarke D S. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria[J]. J Gen Virol, 2004, 85(): 451-461. doi: 10.1099/vir.0.19634-0
-
Gupta R K, Towers G J. A tail of tetherin: how pandemic HIV-1 conquered the world[J]. Cell Host Microbe, 2009, 6(): 393-395. doi: 10.1016/j.chom.2009.11.002
-
Hamman J H, Enslin G M, Kotze A F. Oral delivery of peptide drugs: barriers and developments[J]. Biodrugs, 2005, 19(): 165-177. doi: 10.2165/00063030-200519030-00003
-
Harada T, Tautz N, Thiel H-J. E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies[J]. J Virol, 2000, 74(): 9498-9506. doi: 10.1128/JVI.74.20.9498-9506.2000
-
Hay A J. The action of adamantanamines against influenza A viruses: Inhibition of the M2 ion channel protein[J]. Sem Virol, 1992, 3(): 21-30.
-
Henklein P, Kinder R, Schubert U. Membrane interactions and alignment of structures within the HIV-1 Vpu cytoplasmic domain: effect of phosphorylation of serines 52 and 56[J]. FEBS Lett, 2000, 482(): 220-224. doi: 10.1016/S0014-5793(00)02060-3
-
Holsinger L J, Lamb R A. Influenza virus M2 integral membrane-protein is homotetramer stabilized by formation of disulfide bonds[J]. Virology, 1991, 183(): 32-43. doi: 10.1016/0042-6822(91)90115-R
-
Holsinger L J, Shaughnessy M A, Micko A. Analysis of the posttranslational modifications of the influenza-virus M2 protein[J]. J Virol, 1995, 69(): 1219-1225.
-
Hongo S, Ishii K, Mori K. Detection of ion channel activity in xenopus iaevis oocytes expressing influenza C virus CM2 protein[J]. Arch Virol, 2004, 149(): 35-50.
-
Hu J, Fu R, Cross T A. The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain[J]. Biophys J, 2007, 93(): 276-283. doi: 10.1529/biophysj.106.102103
-
Intharathep P, Laohpongspaisan C, Rungrotmongkol T. How amantadine and rimantadine inhibit proton transport in the M2 protein channel[J]. J Mol Graph Model, 2008, 27(): 342-348. doi: 10.1016/j.jmgm.2008.06.002
-
Isherwood B J, Patel A H. Analysis of the processing and transmembrane topology of the E2p7 protein of hepatitis C virus[J]. J Gen Virol, 2005, 86(): 667-676. doi: 10.1099/vir.0.80737-0
-
Jing X, Ma C, Ohigashi Y. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel[J]. Proc Natl Acad Sci USA, 2008, 105(): 10967-10972. doi: 10.1073/pnas.0804958105
-
Kass I, Arkin I T. How pH opens a H+ channel: the gating mechanism of influenza a M2[J]. Structure, 2005, 13(): 1789-1798. doi: 10.1016/j.str.2005.08.022
-
Klimkait T, Strebel K, Hoggan M D. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release[J]. J Virol, 1990, 64(): 621-629.
-
Kolocouris A, Zikos C, Broadhurst R W. 19F NMR detection of the complex between amantadine and the receptor portion of the influenza A M2 ion channel in DPC micelles[J]. Bioorg Med Chem Lett, 2007, 17(): 3947-3952. doi: 10.1016/j.bmcl.2007.04.100
-
Kukol A, Arkin I T. Structure of the influenza C virus CM2 protein transmembrane domain obtained by site-specific infrared dichroism and global molecular dynamics searching[J]. J Biolog Chem, 2000, 275(): 4225-4229. doi: 10.1074/jbc.275.6.4225
-
Lamb R A, Krug R M. 2001. Orthomyxoviridae: The viruses and their replication. In: Fundamental Virology (Knipe D M, Howley P M. eds. ), Philadelphia, USA. 605-647.
-
Lamb R A, Zebedee S L, Richardson C D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface[J]. Cell, 1985, 40(): 627-633. doi: 10.1016/0092-8674(85)90211-9
-
Lemaitre V, Willbold D, Watts A. Full length Vpu from HIV-1: combining molecular dynamics simulations with NMR spectroscopy[J]. J Biomol Struc Dynamics, 2006, 23(): 485-496. doi: 10.1080/07391102.2006.10507074
-
Marassi F M, Ma C, Gratkowski H. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1[J]. Proc Natl Acad Sci USA, 1999, 96(): 14336-14341. doi: 10.1073/pnas.96.25.14336
-
Merkle I, Van Ooij M J M, Van Kuppeveld F J. Biological significance of a human enterovirus B-specific RNA element in the 3' nontranslated region[J]. J Virol, 2002, (76): 9900-9909.
-
Montal M. Vpu matchmakers as a therapeutic strategy for HIV infection[J]. PLoS Pathogens, 2009, 5(): 1-3.
-
Ma C, Marassi F M. Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1[J]. Protein Sci, 2002, 11(): 546-557.
-
Mould J A, Drury J E, Frings S M. Permeation and activation of the M2 ion channel of influenza A virus[J]. J Biol Chem, 2000, 275(): 31038-31050. doi: 10.1074/jbc.M003663200
-
Mould J A, Paterson R G, Takeda M. Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes[J]. Develop Cell, 2003, 5(): 175-184. doi: 10.1016/S1534-5807(03)00190-4
-
Neil S J D, Zang T, Bieniasz P D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu[J]. Nature, 2008, 451(): 425-U421. doi: 10.1038/nature06553
-
Nieva J L, Agirre A, Nir S. Mechanisms of membrane permeabilization by picornavirus 2B viroporin[J]. FEBS Lett, 2003, 552(): 68-73. doi: 10.1016/S0014-5793(03)00852-4
-
Panayotov P P, Schlesinger R W. Oligomeric organization and strain-specific protelytic modification of the virion-M2 protein of influenza-A-HINI viruses[J]. Virology, 1992, 186(): 352-355. doi: 10.1016/0042-6822(92)90096-8
-
Park S H, Mrse A A, Nevzorov A A. Three-dimensional structure of the channel-forming trans-membrane domain of virus protein "u" (Vpu) from HIV-1[J]. J Mol Biol, 2003, 333(): 409-424. doi: 10.1016/j.jmb.2003.08.048
-
Patargias G, Zitzmann N, Dwek R. Protein-protein interactions: Modeling the hepatitis C virus ion channel p7[J]. J Med Chem, 2006, 49(): 648-655. doi: 10.1021/jm050721e
-
Pavlovic D, Fischer W, Hussey M, et al. 2005. Long alkylchain iminosugars bloc the HCV p7 ion chanel. . In: Advances in Experimental Medicine and Biology (Axford J S. ed), Netherlands: Springer. 564: 3-4.
-
Pavlovic D, Neville D C A, Argaud O. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives[J]. Proc Natl Acad Sci USA, 2003, 100(): 6104-6108. doi: 10.1073/pnas.1031527100
-
Pawlotsky J M. Therapy of hepatitis C: from empiricism to eradication[J]. Hepatology, 2006, 43(): S207-S220. doi: 10.1002/(ISSN)1527-3350
-
Pekosz A, Lamb R A. The CM2 protein of influenza C virus is an oligomeric integral membrane glycoprotein structurally analogous to influenza A virus M-2 and influenza B virus NB proteins[J]. Virology, 1997, 237(): 439-451. doi: 10.1006/viro.1997.8788
-
Pinto L H, Lamb R A. Understanding the mechanism of action of the anti-influenza virus drug amantadine[J]. Trends Microbiol, 1995, 3(): 271-271. doi: 10.1016/S0966-842X(00)88942-8
-
Premkumar A, Wilson L, Ewart G D. Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride[J]. FEBS Lett, 2004, 557(): 99-103. doi: 10.1016/S0014-5793(03)01453-4
-
Sakai A, St Claire M S, Faulk K. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences[J]. Proc Natl Acad Sci USA, 2003, 100(): 11646-11651. doi: 10.1073/pnas.1834545100
-
Sakai A, St. Claire M, Faulk K. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences[J]. Proc Natl Acad Sci USA, 2003, 100(): 11646-11651. doi: 10.1073/pnas.1834545100
-
Sandoval I V, Carrasco L. Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179[J]. J Virolol, 1997, 71(): 4679-4693.
-
Sansom M S P, Kerr I D, Smith G R. The influenza A virus M2 channel: a molecular modeling and simulation study[J]. Virology, 1997, 233(): 163-173. doi: 10.1006/viro.1997.8578
-
Sarah, Schmidt-Rohr, Klaus. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers[J]. Nature, 2010, 463(): 689-692. doi: 10.1038/nature08722
-
Sauter D, Schindler M, Specht A. Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains[J]. Cell Host Microbe, 2009, 6(): 409-421. doi: 10.1016/j.chom.2009.10.004
-
Schnell J R, Chou J J. Structure and mechanism of the M2 proton channel of influenza A virus[J]. Nature, 2008, 451(): 591-595. doi: 10.1038/nature06531
-
Schubert U, Anton L C, Bacik I. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway[J]. J Virol, 1998, 72(): 2280-2288.
-
Schubert U, FerrerMontiel A V, OblattMontal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells[J]. FEBS Lett, 1996, 398(): 12-18. doi: 10.1016/S0014-5793(96)01146-5
-
Smondyrev A M, Voth G A. Molecular dynamics simulation of proton transport through the influenza A virus M2 channel[J]. Biophys J, 2002, 83(): 1987-1996. doi: 10.1016/S0006-3495(02)73960-X
-
Steinmann E, Penin F, Kallis S. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions[J]. Plos Pathogens, 2007, 3(): 962-971.
-
StGelais C, Tuthill T J, Clarke D S. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system[J]. Antiviral Res, 2007, 76(): 48-58. doi: 10.1016/j.antiviral.2007.05.001
-
Stouffer A L, Ma C, Cristan L. The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus[J]. Structure, 2008, 16(): 1067-1076. doi: 10.1016/j.str.2008.04.011
-
Strebel K. HIV accessory genes Vif and Vpu[J]. Adv Pharmacol, 2007, 55(): 199-232. doi: 10.1016/S1054-3589(07)55006-4
-
Stuart J D Neil, Scott W E, Nolwenn Jouvenet. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane[J]. PLoS Pathogens, 2006, 2(): 0354-0367.
-
Sugrue R J, Bahadur G, Zambon M C. Specific structural alteration of the influenza haemagglutinin by amantadine[J]. EMBO J, 1990, 9(): 3469-3476.
-
Sugrue R J, Belshe R B, Hay A J. Palmitoylation of the influenza-A virus M2 protein[J]. Virology, 1990, 179(): 51-56. doi: 10.1016/0042-6822(90)90272-S
-
Sugrue R J, Hay A J. Structural characteristics of the M2 protein of influenza-A viruses evidence that it forms a tetrameric channel[J]. Virology, 1991, 180(): 617-624. doi: 10.1016/0042-6822(91)90075-M
-
Sunstrom N A, Premkumar L S, Premkumar A. Ion channels formed by NB, an influenza B virus protein[J]. J Membr Biol, 1996, 150(): 127-132. doi: 10.1007/s002329900037
-
Taskemasa Sakaguchi Q T, Pinto H Lawrence, Lamb A Robert. The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer[J]. Proc Natl Acad Sci USA, 1997, Vol. 94(): -.
-
Terwilliger E F, Cohen E A, Lu Y C. Functional-role of human immunodeficiency virus type-1 Vpu[J]. Proc Nat Acad Sci USA, 1989, 86(): 5163-5167. doi: 10.1073/pnas.86.13.5163
-
Tokarev A, Skasko M, Fitzpatrick K. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin[J]. Aids Res Human Retroviruses, 2009, 25(): 1197-1210.
-
Van Damme N, Goff D, Katsura C. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein[J]. Cell Host Microb, 2008, 3(): 245-252. doi: 10.1016/j.chom.2008.03.001
-
Van Kuppeveld F J, Galama J M, Zoll J. Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication[J]. J Virol, 1996, 70(): 3876-3886.
-
Van Kuppeveld F J, Hoenderop J G, Smeets R L. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release[J]. EMBO J, 1997, 16(): 3519-3532. doi: 10.1093/emboj/16.12.3519
-
Van Kuppeveld F J, Melchers W J, Kirkegaard K. Structure-function analysis of coxsackie B3 virus protein 2B[J]. Virology, 1997, 227(): 111-118. doi: 10.1006/viro.1996.8320
-
Varthakavi V, Smith R M, Bour S P. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production[J]. Proc Nat Acad Sci USA, 2003, 100(): 15154-15159. doi: 10.1073/pnas.2433165100
-
Veit M, Klenk H D, Kendal A. The M2 protein of influenza-A virus is acylated[J]. J Gen Virol, 1991, 72(): 1461-1465. doi: 10.1099/0022-1317-72-6-1461
-
Wang C, Lamb R A, Pinto L H. Activation of the M2 ion channel of influenza virus-a role for the transmembrane domain histidine residue[J]. Biophys J, 1995, 69(): 1363-1371. doi: 10.1016/S0006-3495(95)80003-2
-
Wang C, Lamb R A, Pinto L H. Activation of the M2 ion channel of influenza virus: A role for the transmembrane domain histidine residue[J]. Biophys J, 1995, 69(): 1363-1371. doi: 10.1016/S0006-3495(95)80003-2
-
Willbold D, Haider S, Volkmann A. Structure of the HIV-1 Vpu protein cytoplasmatic domain in aqueous solution[J]. Biolog Chem Hoppe-Seyler, 1995, 376(): S168-.
-
Willbold D, Hoffmann S, Rosch P. Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution[J]. Eur J Biochem, 1997, 245(): 581-588. doi: 10.1111/ejb.1997.245.issue-3
-
Willey R L, Maldarelli F, Martin M A. Human-immunodeficiency-virus type-1 Vpu protein regulates the formation of intracellular GP 160-CD4 complexes[J]. J Virol, 1992, 66(): 226-234.
-
Woolley G A, Wallace B A. Model ion channels: gramicidin and alamethicin[J]. J Membrane Biol, 1992, 129(): 109-136.
-
Wray V, Schubert U. Structure, phosphorylation, and biological function of the HIV-1 specific virus protein U (Vpu)[J]. Viral Membrane Proteins: Structure, Function, and Drug Design, 2005, 1(): 165-175. doi: 10.1007/0-387-28146-0
-
Ohigashia Yuki, Ma c, Jing X. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition[J]. PNAS, 2009, 106(): 18775-18779. doi: 10.1073/pnas.0910584106